Cargando…
New Tailored RNA-Targeted Organometallic Drug Candidates against Huh7 (Liver) and Du145 (Prostate) Cancer Cell Lines
[Image: see text] New organometallic drug candidates [Ph(2)Sn(HL)], 1, and [Ru(η(6)--p-cymene)(HL)Cl], 2, were designed and synthesized by in situ reaction of a Schiff base ligand (HL) and diphenyltin dichloride and [RuCl(2)(p-cymene)](2), respectively. The drug candidates 1 and 2 have been characte...
Autores principales: | Khan, Huzaifa Yasir, Maurya, Santosh K., Siddique, Hifzur R., Yousuf, Shariq, Arjmand, Farukh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2020
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7331047/ https://www.ncbi.nlm.nih.gov/pubmed/32637795 http://dx.doi.org/10.1021/acsomega.0c01206 |
Ejemplares similares
-
Evaluation of cytotoxic potential of structurally well-characterized RNA targeted ionic non-steroidal anti-inflammatory (NSAID) Cu(ii) & Zn(ii) DACH–mefenamato drug conjugates against human cancer cell lines
por: Khan, Huzaifa Yasir, et al.
Publicado: (2019) -
Modulation of radiosensitivity of DU145 prostate carcinoma cells by simvastatin
por: Korte, Verena, et al.
Publicado: (2022) -
Glucosamine Enhances TRAIL-Induced Apoptosis in the Prostate Cancer Cell Line DU145
por: Sun, Chao, et al.
Publicado: (2019) -
Functional and mutational analysis after radiation and cetuximab treatment on prostate carcinoma cell line DU145
por: Schneider, Raik, et al.
Publicado: (2021) -
Cellular changes in boric acid-treated DU-145 prostate cancer cells
por: Barranco, W T, et al.
Publicado: (2006)